{"id":"vi-dt-typhoid-conjugate-vaccine","safety":{"commonSideEffects":[{"rate":"null","effect":"Pain, redness, or swelling at the injection site"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This vaccine contains inactivated Salmonella Typhi bacteria, which are conjugated to a carrier protein to enhance immunogenicity. Upon administration, the vaccine induces a specific immune response, leading to the production of antibodies that can recognize and neutralize Salmonella Typhi, thereby preventing typhoid fever.","oneSentence":"Vi-DT Typhoid Conjugate Vaccine works by stimulating the body's immune system to produce antibodies against Salmonella Typhi.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:40:34.237Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of typhoid fever"}]},"trialDetails":[{"nctId":"NCT04741828","phase":"PHASE2, PHASE3","title":"Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian","status":"COMPLETED","sponsor":"PT Bio Farma","startDate":"2021-05-03","conditions":"Vaccine","enrollment":188},{"nctId":"NCT05475379","phase":"PHASE1, PHASE2","title":"Non-inferiority Trial of Locally Manufactured Typhoid Conjugate Vaccine 'Typhocon' in Bangladesh","status":"COMPLETED","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2022-07-01","conditions":"Typhoid","enrollment":630},{"nctId":"NCT04051268","phase":"PHASE3","title":"Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)","status":"COMPLETED","sponsor":"PT Bio Farma","startDate":"2020-03-02","conditions":"Safety Issues, Immunogenicity","enrollment":3071},{"nctId":"NCT04204096","phase":"PHASE3","title":"Immune Equivalence Between Multi-dose and Single Dose Formulation of Vi-DT and Their Overall Safety (Phase III)","status":"COMPLETED","sponsor":"International Vaccine Institute","startDate":"2020-02-04","conditions":"Typhoid","enrollment":1800},{"nctId":"NCT03527355","phase":"PHASE2","title":"Safety, Reactogenicity and Immunogenicity of Vi-DT;Typhoid Conjugate Vaccine","status":"COMPLETED","sponsor":"International Vaccine Institute","startDate":"2018-04-18","conditions":"Typhoid","enrollment":285},{"nctId":"NCT02645032","phase":"PHASE1","title":"Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine","status":"COMPLETED","sponsor":"International Vaccine Institute","startDate":"2016-05-19","conditions":"Typhoid","enrollment":144},{"nctId":"NCT03933098","phase":"PHASE3","title":"Immune Non-inferiority and Safety of a Vi-DT Typhoid Conjugate Vaccine","status":"UNKNOWN","sponsor":"International Vaccine Institute","startDate":"2019-11-15","conditions":"Typhoid","enrollment":1800},{"nctId":"NCT03460405","phase":"PHASE2","title":"Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine in Indonesian Adults, Adolescents, Children and Infants","status":"COMPLETED","sponsor":"PT Bio Farma","startDate":"2018-07-16","conditions":"Safety Issues, Immunogenicity","enrollment":600},{"nctId":"NCT03109600","phase":"PHASE1","title":"Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I)","status":"COMPLETED","sponsor":"PT Bio Farma","startDate":"2017-04-18","conditions":"Safety Issues","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":9,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Vi-DT Typhoid Conjugate Vaccine","genericName":"Vi-DT Typhoid Conjugate Vaccine","companyName":"PT Bio Farma","companyId":"pt-bio-farma","modality":"Biologic","firstApprovalDate":"","aiSummary":"Vi-DT Typhoid Conjugate Vaccine works by stimulating the body's immune system to produce antibodies against Salmonella Typhi. Used for Prevention of typhoid fever.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}